JAMA at AHA, Review of MASLD, Primary Biliary Cholangitis, and more
JAMA Editors' Summary
00:00
Oral PCSK9 Inhibitor Lowers LDL in FH
Preeti describes the enlicitide phase 3 trial showing significant LDL reduction in heterozygous familial hypercholesterolemia.
Play episode from 04:17
Transcript
